To All Stanford University Researchers
Environmental Health and Safety, including the Administrative Panel on Biosafety (APB), will be closed during Stanford’s Winter Closure from Monday, December 20, 2021 through Sunday, January 2, 2021. Protocols that are submitted during that time will be addressed upon the University re-opening; as such, please expect some delay from the normal time schedule for review and approval.
Biosafety/the APB will provide critical support on a limited schedule and email messages and HelpSU tickets will be monitored during this time. Please contact the Biosafety Manager (firstname.lastname@example.org) if you have questions.
NEW! In-Person On Demand Biosafety Information Sessions Available – Click here to learn more and request a session
Biosafety is a two way path – to be ‘biosafe’ implies creating a safe working environment for all personnel and ensuring that the work being done does not impact the environment. Biohazardous materials include any organism that can cause disease in humans, or cause significant environmental or agricultural impact, such as:
- Prions and Prion-like Proteins
- Human or primate tissues, fluids, cells, or cell cultures/lines that are known to or are likely to contain infectious organisms
- Human or animal tissues, fluids, cells, or cell cultures/lines that have been exposed to infectious organisms
- Animals known to be reservoirs of zoonotic diseases
The Biosafety program oversees the use of recombinant and synthetic nucleic acid molecules. This includes:
- Recombinant and synthetic nucleic acid molecules
- Transgenic animals
- Transgenic plants
- Human gene transfer or studies using recombinant DNA
You may also be directed to Biosafety if your Institutional Review Board (IRB) or Administrative Panel on Laboratory Animal Care (APLAC) protocol indicates a need for APB review.